We are live on ! Find out more
INKT icon

MiNK Therapeutics
INKT

34 hedge funds and large institutions have $800K invested in MiNK Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.22% less ownership

Funds ownership: 0.43% → 0.21% (-0.22%)

19% less funds holding

Funds holding: 42 → 34 (-8)

56% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 16

74% less capital invested

Capital invested by funds: $3.1M → $800K (-$2.3M)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
34
Holders Change
-8
Holders Change %
-19.05%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
16
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$36.2K
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$3.16K
3
C
Covestor
United Kingdom
+$814
4
UBS Group
UBS Group
Switzerland
+$651
5
Goldman Sachs
Goldman Sachs
New York
+$488

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$682K
2
AG
Artal Group
Luxembourg
-$368K
3
Renaissance Technologies
Renaissance Technologies
New York
-$143K
4
Citadel Advisors
Citadel Advisors
Florida
-$107K
5
VF
Virtu Financial
New York
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$125 – – –
QCG
27
Quadrant Capital Group
Ohio
$80 -$163 -10 -59%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$70 -$15.4K -943 -99%
SN
29
Sittner & Nelson
Oregon
$64 – – –
KFI
30
Key Financial Inc
Pennsylvania
$47 – – –
S
31
SignatureFD
Georgia
$20 -$65 -4 -67%
LC
32
Lindbrook Capital
California
$15 -$33 -2 -67%
PA
33
Parallel Advisors
California
$11 – – –
HIA
34
Harbor Investment Advisory
Maryland
$6 – – –
AF
35
Allworth Financial
California
$3 – – –
DTC
36
Deep Track Capital
Connecticut
– -$682K -32,487 Closed
Citadel Advisors
37
Citadel Advisors
Florida
– -$107K -5,105 Closed
VF
38
Virtu Financial
New York
– -$30K -1,423 Closed
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
– -$24.2K -1,154 Closed
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
– -$65 -3 Closed
IPW
41
Impact Partnership Wealth
Georgia
– -$13 -1 Closed
Legal & General Group
42
Legal & General Group
United Kingdom
– -$16 -1 Closed
1
2

INKT Hedge Fund Activity: Q3 2023 in Review

34 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in MiNK Therapeutics (INKT) for Q3 2023, worth a combined $800K — down 74% from $3.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of INKT and 1 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 7 added.

The largest buyer was CAPTRUST Financial Advisors, adding an estimated $36.2K. The largest seller was Deep Track Capital, exiting entirely with an estimated $682K sold.

  • 34 institutional investors held MiNK Therapeutics (INKT) as of Q3 2023, down from 42 in Q2 2023.
  • Funds reported $800K of MiNK Therapeutics stock for Q3 2023, down 74% quarter-over-quarter.
  • 1 fund opened new MiNK Therapeutics positions in Q3 2023 and 7 closed out, a net change of -6 holders.
  • The largest MiNK Therapeutics buyer in Q3 2023 was CAPTRUST Financial Advisors, an estimated $36.2K added.
  • The largest MiNK Therapeutics seller in Q3 2023 was Deep Track Capital, an estimated $682K sold.

Based on aggregated 13F filings for Q3 2023.